Found: 10
Select item for more details and to access through your institution.
Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2004, v. 3, p. 7, doi. 10.1186/1475-2840-3-7
- By:
- Publication type:
- Article
Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient.
- Published in:
- Cardiovascular Diabetology, 2004, v. 3, p. 5, doi. 10.1186/1475-2840-3-5
- By:
- Publication type:
- Article
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept.
- Published in:
- Cardiovascular Diabetology, 2004, v. 3, p. 4, doi. 10.1186/1475-2840-3-4
- By:
- Publication type:
- Article
Cardiovascular adaptations to exercise training in postmenopausal women with type 2 diabetes mellitus.
- Published in:
- Cardiovascular Diabetology, 2004, v. 3, p. 3, doi. 10.1186/1475-2840-3-3
- By:
- Publication type:
- Article
The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481].
- Published in:
- Cardiovascular Diabetology, 2004, v. 3, p. 9, doi. 10.1186/1475-2840-3-9
- Publication type:
- Article
Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study).
- Published in:
- Cardiovascular Diabetology, 2004, v. 3, p. 8, doi. 10.1186/1475-2840-3-8
- By:
- Publication type:
- Article
An interaction between the interleukin-6 -174G>C gene variant and urinary protein excretion influences plasma oxidative stress in subjects with type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2004, v. 3, p. 2, doi. 10.1186/1475-2840-3-2
- By:
- Publication type:
- Article
Arterial heparan sulfate is negatively associated with hyperglycemia and atherosclerosis in diabetic monkeys.
- Published in:
- Cardiovascular Diabetology, 2004, v. 3, p. 6, doi. 10.1186/1475-2840-3-6
- By:
- Publication type:
- Article
Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
- Published in:
- Cardiovascular Diabetology, 2004, v. 3, p. 1, doi. 10.1186/1475-2840-3-10
- By:
- Publication type:
- Article
Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation.
- Published in:
- Cardiovascular Diabetology, 2004, v. 3, p. 1, doi. 10.1186/1475-2840-3-1
- By:
- Publication type:
- Article